2-(Pyrrolidin-1-yl)ethyl-7-chloro-5,12-dioxo-5,12-dihydroindolizino[2,3-g]quinoline-6-carboxylate

ID: ALA4169029

PubChem CID: 145952804

Max Phase: Preclinical

Molecular Formula: C22H18ClN3O4

Molecular Weight: 423.86

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1c2cccnc2C(=O)c2c1c(C(=O)OCCN1CCCC1)c1c(Cl)cccn21

Standard InChI:  InChI=1S/C22H18ClN3O4/c23-14-6-4-10-26-18(14)16(22(29)30-12-11-25-8-1-2-9-25)15-19(26)21(28)17-13(20(15)27)5-3-7-24-17/h3-7,10H,1-2,8-9,11-12H2

Standard InChI Key:  UQZGCSOXVCNGCV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
    1.5091  -15.6628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5080  -16.4823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2160  -16.8913    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2143  -15.2539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9229  -15.6592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9263  -16.4844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6386  -16.8918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6319  -15.2414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3488  -15.6533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3505  -16.4762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1309  -15.3975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6159  -16.0621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1286  -16.7292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4608  -17.4806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2813  -17.5713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7686  -16.9043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4355  -16.1465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6423  -17.7090    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6274  -14.4242    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5346  -14.6847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3518  -14.6779    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1202  -13.9804    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7545  -13.9669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5717  -13.9601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9744  -13.2491    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9166  -15.4859    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    8.7856  -13.1563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9489  -12.3556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2378  -11.9528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6351  -12.5047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  8  1  0
  6  7  1  0
  7 10  1  0
  9  8  1  0
  9 10  2  0
 10 13  1  0
 12 11  2  0
 11  9  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  7 18  2  0
  8 19  2  0
 11 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 17 26  1  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4169029

    ---

Associated Targets(Human)

HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Huh-7 (12904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Topoisomerase I (119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DNA (609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 423.86Molecular Weight (Monoisotopic): 423.0986AlogP: 3.02#Rotatable Bonds: 4
Polar Surface Area: 80.98Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.88CX LogP: 2.68CX LogD: 2.56
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.47Np Likeness Score: -0.86

References

1. Yu Q, Yang H, Zhu TW, Yu LM, Chen JW, Gu LQ, Huang ZS, An LK..  (2018)  Synthesis, cytotoxicity and structure-activity relationship of indolizinoquinolinedione derivatives as DNA topoisomerase IB catalytic inhibitors.,  152  [PMID:29705710] [10.1016/j.ejmech.2018.04.040]

Source